We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gliomas Rapidly Diagnosed from Serum Samples

By LabMedica International staff writers
Posted on 10 Dec 2013
Current methods can diagnose brain cancer within two to three days, but a new technique has been created in which the disease could be diagnosed in just half an hour.

A rapid diagnostic method based upon serum samples would allow for a relatively noninvasive test and open up the possibility of screening for brain cancer using a Bioplex immunoassay.

Scientists at the University of Central Lancashire (Preston, UK) collected blood samples from 50 patients with clinically confirmed glioblastoma (GBM) brain tumors and 25 normal patients. More...
The average age of the entire sample set is 60.2 years. The Bioplex suspension array system was used to quantitate the cytokine and angiogenesis factor secretion. The technology incorporates 100 color-coded bead sets each of which is conjugated to a specific reactant. Identification is based around a laminar flow system of flow cytometry that identifies and quantitates each specific reaction based on bead color and fluorescence.

Immunohistochemical staining of formalin-fixed, paraffin embedded tissue sections of the patients used for the serum analysis was performed using antibodies raised against Follistatin-288 (AbD Serotec, Kidlington, UK). The secondary antibody, blocking reagents, avidin-biotin complex, and chromagen were in the Universal Vectastain kit (Vector Labs; Burlingame, CA, USA). The Fourier transform infrared FTIR-410 Specac ATR single reflection diamond Golden Gate spectrometer (Jasco; Easton, MD, USA) was used in absorption mode to collect spectra from all serum samples.

When the investigators transmitted infrared light directly at the serum, the light had the ability to detect its molecular vibration, meaning they could determine whether the gliomas were cancerous or not. This test can achieve a diagnosis within 30 minutes. The analytes that show a statistical difference between control serum and GBM are angiopoietin, follistatin, human growth factor, interleukin-8, leptin, platelet-derived growth factor-BB (PDGF-BB) and platelet endothelial cell adhesion molecule-1 (PECAM-1).

Matthew J. Baker, the senior author said, “The result we have achieved is a milestone and has the ability to revolutionize the clinical environment by providing objective measures for diagnoses, enabling increased efficiency and economic impact upon the health services. We hope this will also help to relieve some of the emotional stress patients experience waiting for test results.” The study was originally published in the November 2013 issue of the journal Analytical and Bioanalytical Chemistry.

Related Links:

University of Central Lancashire
AbD Serotec 
Jasco 




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

High-grade serous ovarian cancer is often diagnosed at an advanced stage, limiting opportunities for early intervention. The disease frequently originates in the fallopian tube as serous tubal intraepithelial... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.